Literature DB >> 6791221

Enduring behavioural and biochemical effects in the adult rat after prolonged postnatal administration of haloperidol.

V Cuomo, R Cagiano, E Coen, I Mocchetti, F Cattabeni, G Racagni.   

Abstract

Rats were administered 0.5 mg/kg SC of haloperidol (H) or saline (S) daily from day 1 after birth until 20 days of age. At 60 days of age (40 days after the postnatal treatment with H or S was interrupted) the stereotyped behaviour and the effects on locomotor activity elicited by apomorphine in S- and H-pretreated rats were investigated. The intensity of apomorphine (0.5--1 mg/kg, SC)-induced stereotyped behaviour was significantly greater in the H-pretreated group than in S-pretreated animals and this was accompanied by a much more marked reduction of locomotor activity in H-pretreated than in S-pretreated rats. Finally, at 80 days of age (60 days after the postnatal treatment with H or S was interrupted) rats were subjected to a Differential Reinforcement of Low Rates schedule (DRL 15-s). The results indicate that the acquisition of the DRL task performance criterion (Rs/Rf less than or equal to 2.5) was significantly more rapid on S-pretreated rats than in H-pretreated ones. In parallel biochemical experiments, acute H produced smaller increases in dopamine turnover in chronic H-treated rats compared with S-treated controls. These data indicate that H treatment in neonatal rats induces behavioural and biochemical changes which can be observed up to 60 days after H withdrawal.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6791221     DOI: 10.1007/BF00432686

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  15 in total

1.  Toxic effects of tranquilizers administered to gravid rats.

Authors:  J WERBOFF; E L DEMBICKI
Journal:  J Neuropsychiatr       Date:  1962 Nov-Dec

2.  Technique for assessing the effects of drugs on timing behavior.

Authors:  M SIDMAN
Journal:  Science       Date:  1955-11-11       Impact factor: 47.728

3.  Behavioral teratogenesis: a critical evaluation.

Authors:  I Coyle; M J Wayner; G Singer
Journal:  Pharmacol Biochem Behav       Date:  1976-02       Impact factor: 3.533

4.  Mass fragmentographic determination of some acidic and alcoholic metabolites of biogenic amines in the rat brain.

Authors:  F Karoum; J C Gillin; R J Wyatt
Journal:  J Neurochem       Date:  1975-11       Impact factor: 5.372

5.  Seizure susceptibility and avoidance conditioning in adult rats treated prenatally with chlorpromazine.

Authors:  M Golub; C Kornetsky
Journal:  Dev Psychobiol       Date:  1974-01       Impact factor: 3.038

6.  Factors governing the vulnerability of DRL operant performance to the effects of ethanol.

Authors:  F A Holloway; R A Wansley
Journal:  Psychopharmacologia       Date:  1973-02-20

7.  On the mode of action of apomorphine.

Authors:  B Costall; R J Naylor
Journal:  Eur J Pharmacol       Date:  1973-03       Impact factor: 4.432

8.  Effects of prenatal administration of psychotropic drugs on behavior of developing rats.

Authors:  C V Clark; D Gorman; A Vernadakis
Journal:  Dev Psychobiol       Date:  1970       Impact factor: 3.038

9.  Unilateral catecholamine depletion of the corpus striatum and amphetamine-induced turning: an ontogenetic study.

Authors:  B C White; W N Tapp
Journal:  Psychopharmacology (Berl)       Date:  1977-07-18       Impact factor: 4.530

10.  Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine.

Authors:  I Creese; S D Iversen
Journal:  Brain Res       Date:  1973-06-15       Impact factor: 3.252

View more
  9 in total

1.  Early-life risperidone enhances locomotor responses to amphetamine during adulthood.

Authors:  Bobbie Lee Stubbeman; Clifford J Brown; Justin R Yates; Mark E Bardgett
Journal:  Eur J Pharmacol       Date:  2017-07-14       Impact factor: 4.432

2.  Evaluation of age and sex differences in locomotion and catalepsy during repeated administration of haloperidol and clozapine in adolescent and adult rats.

Authors:  Jenny L Wiley; Rhys L Evans
Journal:  Pharmacol Res       Date:  2008-08-22       Impact factor: 7.658

3.  Delayed yet persistent effects of daily risperidone on activity in developing rats.

Authors:  Rachel M Stevens; Matthew A Gannon; Molly S Griffith; Mark E Bardgett
Journal:  Behav Pharmacol       Date:  2016-08       Impact factor: 2.293

4.  Early-life risperidone administration alters maternal-offspring interactions and juvenile play fighting.

Authors:  Matthew A Gannon; Clifford J Brown; Rachel M Stevens; Molly S Griffith; Cecile A Marczinski; Mark E Bardgett
Journal:  Pharmacol Biochem Behav       Date:  2015-01-17       Impact factor: 3.533

Review 5.  Appropriate end points for the characterization of behavioral changes in developmental toxicology.

Authors:  V Cuomo; M A De Salvia; S Petruzzi; E Alleva
Journal:  Environ Health Perspect       Date:  1996-04       Impact factor: 9.031

6.  Behavioural and biochemical effects in the adult rat after prolonged postnatal administration of clozapine.

Authors:  V Cuomo; R Cagiano; I Mocchetti; E Coen; F Cattabeni; G Racagni
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

7.  Early postnatal chlordiazepoxide administration: permanent behavioural effects in the mature rat and possible involvement of the GABA-benzodiazepine system.

Authors:  E Coen; M P Abbracchio; W Balduini; R Cagiano; V Cuomo; G Lombardelli; G Peruzzi; M C Ragusa; F Cattabeni
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

8.  Adult rats treated with risperidone during development are hyperactive.

Authors:  Mark E Bardgett; Julie M Franks-Henry; Kristin R Colemire; Kathleen R Juneau; Rachel M Stevens; Cecile A Marczinski; Molly S Griffith
Journal:  Exp Clin Psychopharmacol       Date:  2013-06       Impact factor: 3.157

9.  Antipsychotic-induced suppression of locomotion in juvenile, adolescent and adult rats.

Authors:  Jenny L Wiley
Journal:  Eur J Pharmacol       Date:  2007-09-26       Impact factor: 4.432

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.